AKT1 and melanoma: Using the tumor NC1 domain of collagen Type XIX [C1(XIX)], Oudart et al. were able to target the αvβ3 integrin interaction and demonstrated the inhibition of migration, invasion, and PI3K/Akt/mTOR and FAK pathways in melanoma cells and preclinical melanoma model [89,90,91].